Platforms that enable high-plex proteomics for immune-oncology applications include advanced multiplex systems like the NULISAseq™ Inflammation Panel 250, which is specifically designed for deep profiling of immune responses in complex diseases. Built on NULISA™ technology, this platform allows simultaneous measurement of 250+ immune and inflammatory proteins from a single sample,...